427 related articles for article (PubMed ID: 26342897)
41. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.
Sanchez-Guajardo V; Febbraro F; Kirik D; Romero-Ramos M
PLoS One; 2010 Jan; 5(1):e8784. PubMed ID: 20098715
[TBL] [Abstract][Full Text] [Related]
42. TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models.
Guo Y; Wei X; Yan H; Qin Y; Yan S; Liu J; Zhao Y; Jiang F; Lou H
FASEB J; 2019 Nov; 33(11):12164-12174. PubMed ID: 31370707
[TBL] [Abstract][Full Text] [Related]
43. Microglia as modulators of exosomal alpha-synuclein transmission.
Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
[TBL] [Abstract][Full Text] [Related]
44. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
Miao Y; Meng H
Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
[TBL] [Abstract][Full Text] [Related]
45. Synuclein activates microglia in a model of Parkinson's disease.
Su X; Maguire-Zeiss KA; Giuliano R; Prifti L; Venkatesh K; Federoff HJ
Neurobiol Aging; 2008 Nov; 29(11):1690-701. PubMed ID: 17537546
[TBL] [Abstract][Full Text] [Related]
46. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.
Harms AS; Cao S; Rowse AL; Thome AD; Li X; Mangieri LR; Cron RQ; Shacka JJ; Raman C; Standaert DG
J Neurosci; 2013 Jun; 33(23):9592-600. PubMed ID: 23739956
[TBL] [Abstract][Full Text] [Related]
47. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes.
Bliederhaeuser C; Grozdanov V; Speidel A; Zondler L; Ruf WP; Bayer H; Kiechle M; Feiler MS; Freischmidt A; Brenner D; Witting A; Hengerer B; Fändrich M; Ludolph AC; Weishaupt JH; Gillardon F; Danzer KM
Acta Neuropathol; 2016 Mar; 131(3):379-91. PubMed ID: 26576561
[TBL] [Abstract][Full Text] [Related]
48. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
49. Age-related increase in caveolin-1 expression facilitates cell-to-cell transmission of α-synuclein in neurons.
Ha TY; Choi YR; Noh HR; Cha SH; Kim JB; Park SM
Mol Brain; 2021 Jul; 14(1):122. PubMed ID: 34321069
[TBL] [Abstract][Full Text] [Related]
50. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
51. DJ-1 facilitates the interaction between STAT1 and its phosphatase, SHP-1, in brain microglia and astrocytes: A novel anti-inflammatory function of DJ-1.
Kim JH; Choi DJ; Jeong HK; Kim J; Kim DW; Choi SY; Park SM; Suh YH; Jou I; Joe EH
Neurobiol Dis; 2013 Dec; 60():1-10. PubMed ID: 23969237
[TBL] [Abstract][Full Text] [Related]
52. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
[TBL] [Abstract][Full Text] [Related]
53. Microglia-specific knock-out of NF-κB/IKK2 increases the accumulation of misfolded α-synuclein through the inhibition of p62/sequestosome-1-dependent autophagy in the rotenone model of Parkinson's disease.
Rocha SM; Kirkley KS; Chatterjee D; Aboellail TA; Smeyne RJ; Tjalkens RB
Glia; 2023 Sep; 71(9):2154-2179. PubMed ID: 37199240
[TBL] [Abstract][Full Text] [Related]
54. The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease.
He Q; Zhang S; Wang J; Ma T; Ma D; Wu L; Zhou M; Zhao L; Chen Y; Liu J; Chen W
Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38367134
[TBL] [Abstract][Full Text] [Related]
55. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
[TBL] [Abstract][Full Text] [Related]
56. α-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with reduced inward current and Ca(2+) influx upon NMDA stimulation.
Chen Y; Yang W; Li X; Li X; Yang H; Xu Z; Yu S
Neuroscience; 2015 Aug; 300():297-306. PubMed ID: 26003734
[TBL] [Abstract][Full Text] [Related]
57. Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
Hoffmann A; Ettle B; Bruno A; Kulinich A; Hoffmann AC; von Wittgenstein J; Winkler J; Xiang W; Schlachetzki JCM
Biochem Biophys Res Commun; 2016 Oct; 479(4):881-886. PubMed ID: 27666480
[TBL] [Abstract][Full Text] [Related]
58. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
Filippini A; Gennarelli M; Russo I
Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
[TBL] [Abstract][Full Text] [Related]
59. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
Kim S; Park JM; Moon J; Choi HJ
Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
[TBL] [Abstract][Full Text] [Related]
60. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.
Rojanathammanee L; Murphy EJ; Combs CK
J Neuroinflammation; 2011 May; 8():44. PubMed ID: 21554732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
